Skip to content

Menu

Network by SubjectChannelsBlogsHomeAboutContact
AI Legal Journal logo
Subscribe
Search
Close
PublishersBlogsNetwork by SubjectChannels
Subscribe

The New Vaccine Patchwork: State Alliances and Regulatory Shifts

By Sukrti Thonse on September 11, 2025
Email this postTweet this postLike this postShare this post on LinkedIn

In recent weeks, vaccine policy has become a flashpoint at the state level. On September 3, 2025, the governors of Oregon, California, and Washington inaugurated a West Coast Health Alliance, a regional partnership aimed at preserving scientific integrity in vaccine policy amid growing skepticism toward federal health leadership. Through this partnership, the three states will start coordinating health guidelines by aligning immunization recommendations informed by respected national medical organizations and scientific evidence-based recommendations from trusted scientists, clinicians, and other public health leaders. While each state will independently pursue strategies shaped by their unique demographics, geographics, and laws, the Alliance’s coordinated plan is intended to ensure consistency and transparency across the West Coast in determining who should receive vaccines and under what circumstances.

In subsequent developments, Hawaii announced it would join the Alliance, expanding the collaboration to four states united behind evidence-driven immunization recommendations, respecting tribal sovereignty, and acknowledging each jurisdiction’s unique regulatory needs.

By contrast, Florida has moved in the opposite direction. Florida surgeon general, Joseph Ladapo, stated on September 3 that the state plans to end all state vaccine mandates, including for students to attend schools. Ladapo said his agency would roll back mandates for a half-dozen or so vaccines under its authority but that the agency will need to work with the Florida legislature on a broader package of reforms. He did not specify which vaccine mandates his agency would do away with.

Currently, all states have vaccine requirements to attend public schools with specific exceptions that vary by state (mainly for medical and religious reasons). This move to reverse the vaccine mandate for school children, and possibly a larger group, shows a significant shift in state-level policy and signals growing divergence nationwide.

What This Means for New Jersey Providers and Health Systems

These developments highlight how states are increasingly asserting authority over vaccine policy, diverging from federal standards. While most states have historically aligned closely with CDC guidance, the current climate suggests we may see greater variability in immunization requirements, school-entry rules, and employer/healthcare provider obligations.

For New Jersey providers, this trend matters for several reasons:

  • Regulatory Drift: If states like California or Florida test new approaches, others may follow, either strengthening or loosening requirements.
  • Compliance Complexity: Multi-state providers, payors, and vendors will need to navigate inconsistent state rules.
  • Future in NJ: New Jersey could face pressure to adopt its own state-specific vaccine policies if public confidence in federal guidance erodes further.

Greenbaum’s Healthcare team is actively monitoring these state-led initiatives. We are prepared to advise physician groups, health systems, and management companies on compliance with evolving immunization requirements, the potential need to adjust policies for multi-state operations, and any state-specific rulemaking that could impact school-based, workplace, and clinical vaccination obligations.

Photo of Sukrti Thonse Sukrti Thonse

Associate, Corporate and Healthcare

Sukrti supports the firm’s representation of clients in corporate transactions and in legal matters related to the healthcare sector, with experience across all stages of the corporate life cycle.

Her work includes the formation of corporate entities, including capitalization…

Associate, Corporate and Healthcare

Sukrti supports the firm’s representation of clients in corporate transactions and in legal matters related to the healthcare sector, with experience across all stages of the corporate life cycle.

Her work includes the formation of corporate entities, including capitalization structures, fundraising, financing, strategic issues, and negotiations with investors. She provides support related to merger and acquisition transactions, venture capital financings, public offerings, regulatory due diligence reviews, private equity investments, regulatory disclosures in securities filings, and transactions involving FDA-regulated entities. She also assists clients with issues related to corporate governance and day-to-day business operations.

Sukrti has developed expertise related to HIPAA compliance and other healthcare privacy issues. She provides guidance on regulatory frameworks, including those associated with FDA regulations, the Anti-Kickback Statute, Stark Law, and other healthcare compliance concerns.

Contact information:

sthonse@greenbaumlaw.com | 732.476.2480 | vCard

For more information visit the Greenbaum, Rowe, Smith & Davis LLP website.

Read more about Sukrti ThonseSukrti's Linkedin Profile
Show more Show less
  • Posted in:
    Health Care
  • Blog:
    Healthcare Perspectives
  • Organization:
    Greenbaum, Rowe, Smith & Davis LLP
  • Article: View Original Source

LexBlog logo
Copyright © 2025, LexBlog. All Rights Reserved.
Legal content Portal by LexBlog LexBlog Logo